Touchstone International Medical Science Co Ltd Cash Flow-to-Debt Ratio
Touchstone International Medical Science Co Ltd cash flow-to-debt ratio. Touchstone International Medical Science Co Ltd (688013) has a Cash Flow-to-Debt Ratio of 0.35x as of September 2025, meaning its operating cash flow of CN¥27.05 Million could theoretically repay 0% of its total liabilities (CN¥76.41 Million) in one year. Check Touchstone International Medical Science cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Touchstone International Medical Science Co Ltd (2017–2024)
Cash flow-to-debt ratio of Touchstone International Medical Science Co Ltd from 2017 to 2024. Historical debt coverage capacity for Touchstone International Medical Science Co Ltd across 8 annual periods. Check 688013 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Touchstone International Medical Science Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2024)
Touchstone International Medical Science Co Ltd cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Touchstone International Medical Science Co Ltd. For the full cash flow conversion analysis, see 688013 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | CN¥53.41 Million | CN¥55.81 Million | ▼ -36.5% |
| 2023 | 1.51x | CN¥82.95 Million | CN¥55.08 Million | ▲ +4.7% |
| 2022 | 1.44x | CN¥50.40 Million | CN¥35.04 Million | ▼ -22.9% |
| 2021 | 1.86x | CN¥60.98 Million | CN¥32.71 Million | ▼ -14.3% |
| 2020 | 2.17x | CN¥42.08 Million | CN¥19.35 Million | ▲ +10.7% |
| 2019 | 1.96x | CN¥34.82 Million | CN¥17.72 Million | ▲ +94.3% |
| 2018 | 1.01x | CN¥34.44 Million | CN¥34.05 Million | ▲ +140.2% |
| 2017 | 0.42x | CN¥7.88 Million | CN¥18.72 Million | — |